Las Vegas, NV -- (SBWIRE) -- 09/30/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is on: Arbitron Inc. (NYSE:ARB), Keryx Biopharmaceuticals (NASDAQ:KERX), Krispy Kreme Doughnuts (NYSE:KKD), Medical Properties Trust, Inc. (NYSE:MPW)
Arbitron Inc. (NYSE:ARB) showed no change on above-normal volume of 1.30M shares. The stock settled at $48 after floating in a range of $47.99 to $48.01. Its latest price has reached market capitalization of $1.29 billion. Its 52-week range has been $34.64 to $48.01. Arbitron Inc. operates as a media and marketing information services company in the United States and internationally. Its primary service is estimating the size and composition of radio audiences in local markets and of audiences to network radio programming and commercials in the United States.
Can Investors Bet on ARB after this News update? Find out in this Research Report
Keryx Biopharmaceuticals (NASDAQ:KERX) traded down on a volume of 1.30 million, lower than its standard daily volume. Shares have dropped-1.17% to $10.10. Over the last twelve months, the stock has gained 258.16% and faced a worst price of $2.23. Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States.
Has KERX Found The Bottom And Ready To Gain Momentum? Find Out Here
Krispy Kreme Doughnuts (NYSE:KKD) settled 2.48% higher at $19.82 on below -normal volume of 1.30M shares during the last trading day. The stock has its 12-month high at $23.57 and 52-week low price was $6.77. It traded in a range of $19.26 to $20.11 during the last trading day. Krispy Kreme Doughnuts, Inc., together with its subsidiaries, operates as a branded retailer and wholesaler of doughnuts, beverages, and treats and packaged sweets worldwide.
Why Should Investors Buy KKD After the Recent Fall? Just Go Here and Find Out
In the last trading session, Medical Properties Trust, Inc. (NYSE:MPW) was down on low volume, trading at a volume of 1.29M shares versus its average daily volume of 1.77 million shares. At $12.25, the stock has attained market capitalization of $1.84 billion. Medical Properties Trust, Inc. operates as a real estate investment trust (REIT) in the United States. It acquires, develops, and invests in healthcare facilities; and leases healthcare facilities to healthcare operating companies and healthcare providers.
Why Should Investors Buy MPW After the Recent Fall? Just Go Here and Find Out
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)